Sort
25,944 grants matching “neurodegeneration”
Multimodal MRI Biomarker of Mild Cognitive Impairment in Breast Cancer
$529,314Jeffrey Scott Wefel · University Of Tx Md Anderson Can Ctr · R01 · FY2014 · NR
Using Multiplex Families to map Genes that Modify Susceptibility and Age at Onset
$529,213Cyrus P Zabetian · University Of Washington · R01 · FY2011 · NS
A Unified Atlas of Dynamic tRNA Function
$529,206Todd Michael Lowe · University Of California Santa Cruz · R01 · FY2021 · HG
Cognitive decline and synaptic change in the aging marmoset
$529,100John H Reynolds · Salk Institute For Biological Studies · R21 · FY2020 · AG
Therapeutic Relevance of Cannabinoids for Alzheimer's Disease
$529,100Pamela Anne Maher · Salk Institute For Biological Studies · R21 · FY2020 · AG
Molecular basis of lysosomal dysfunction in Alzheimer's disease and approaches to therapeutic remediation
$529,038Ralph A. Nixon · Nathan S. Kline Institute For Psych Res · P01 · FY2019 · AG
Molecular basis of lysosomal dysfunction in Alzheimer's disease and approaches to therapeutic remediation
$529,038Ralph A. Nixon · Nathan S. Kline Institute For Psych Res · P01 · FY2018 · AG
Ethanol and aldehyde dehydrogenases in health and disease
$528,998Daria Mochly-Rosen · Stanford University · R01 · FY2023 · AA
Relating Neuroimmune and Neurovascular Alterations During Alzheimer's Disease Progression
$528,916Mohammad Abbas Yaseen · Northeastern University · R01 · FY2021 · AA
CORE A: Administrative Core
$528,791Jessica Kirkland Caldwell · Cleveland Clinic Foundation · P20 · FY2022 · GM
The Hippo signaling pathway as a target of intervention for Alzheimerâs disease
$528,723Qitao Ran · University Of Texas Hlth Science Center · R01 · FY2025 · AG
Cognitive impairment in the DPPOS cohort and its neuropathologic, neurophysiologic, sociodemographic, and behavioral correlates
$528,612James McCallum Noble · Columbia University Health Sciences · U19 · FY2023 · AG
Viral Host Interactions in SIV Cardiac Dysfunction
$528,609Joseph L Mankowski · Johns Hopkins University · R01 · FY2007 · HL
Neurodegeneration in Aged SIV-Infected Primates
$528,568Clayton A. Wiley · University Of Pittsburgh At Pittsburgh · R01 · FY2012 · MH
Administrative Core
$528,557James Bruce Leverenz · Cleveland Clinic Lerner Com-Cwru · P30 · FY2025 · AG
BRAIN MRI &MRS CHANGES IN FIRST EPISODE SCHIZOPHRENIA
$528,379University Of North Carolina Chapel Hill · R01 · FY2003 · MH
Relating neuroimmune and neurovascular alterations during Alzheimer's Disease progression
$528,325Mohammad Abbas Yaseen · Massachusetts General Hospital · R01 · FY2019 · AA
Longitudinal predictive modeling for tau in Alzheimer's disease
$528,233Joyita Dutta · Massachusetts General Hospital · R01 · FY2025 · AG
Novel biological insights by utilizing mitochondrial genome information from HuBMAP resources
$528,000Liming Pei · Children'S Hosp Of Philadelphia · U01 · FY2022 · HL
Essential Function of miR-29 in the Mature Brain
$527,934Mohanish Deshmukh · Univ Of North Carolina Chapel Hill · R01 · FY2017 · AG
Spatial control of membrane traffic by septin GTPases
$527,873Elias T Spiliotis · University Of Virginia · R35 · FY2025 · GM
Prostanoid Modulators that Reduce Brain Injury After Seizures
$527,623Raymond J Dingledine · Emory University · U01 · FY2015 · NS
Prostanoid Modulators that Reduce Brain Injury After Seizures
$527,623Raymond J Dingledine · Emory University · U01 · FY2014 · NS
Prostanoid Modulators that Reduce Brain Injury After Seizures
$527,623Raymond J Dingledine · Emory University · U01 · FY2013 · NS
Prostanoid Modulators that Reduce Brain Injury After Seizures
$527,623Raymond J Dingledine · Emory University · U01 · FY2012 · NS